Tenofovir disoproxil

Sold as Medpro tenofovir, Cipla tenofovir, Aspen tenofovir, Sonke tenofovir, Zefin, Cylor, Vireno, Adco-tenofovir, Taidof, Tenofovir propan, Ricovir, Hetero tenofovir, Tenofovir winthrop, SPEC tenofovir, Riovex, Tenolaurus, Viread

C₉H₁₄N₅O₄P287.21 g/mol

[(2R)-1-(6-Aminopurin-9-yl)propan-2-yl]oxymethylphosphonic acid

Drag to rotate. Structure from PubChem CID 464205.

Loading Wikipedia summary

Registration

Applicants: 12
Registrations: 17
Schedule source: Consolidated Schedules 06 July 2026

Applicants and registrations

Applicant	Brands	Dosages	Registrations	Schedule	Leaflets
Cipla Medpro (Pty) LtdCancelled	Medpro tenofovir, Cipla tenofovir	300	420560, 420561	S4	None
Pharmacare limited û woodmeadCertificate held by Aspen pharmacare2 of 3 cancelled	Aspen tenofovir, Tenolaurus, Viread	300mg	430181, 520388, A400681	S4	PI PIL
Ranbaxy (SA) (Pty) LtdCancelled	Sonke tenofovir	300	430695	S4	None
Novagen Pharma (Pty) LtdCancelled	Zefin	300 mg	440307	S4	None
Aurobindo Pharma (Pty) Ltd	Cylor	300 mg	440308	S4	None
Aurogen South Africa (Pty) Ltd	Vireno	300 mg	440309	S4	None
Adcock ingram limited1 of 3 cancelled	Adco-tenofovir, Taidof, Tenofovir propan	300 mg	440332, 440333, 440334	S4	None
Viatris Healthcare (Pty) Ltd	Ricovir	Not stated	450825	S4	None
Hetero Drugs South Africa (Pty) Ltd	Hetero tenofovir	300 mg	460019	S4	None
Winthrop Pharmaceuticals (Pty) Ltd	Tenofovir winthrop	Not stated	460040	Not determined	None
Specpharm (Pty) LtdCancelled	SPEC tenofovir	300	460510	S4	None
Macleods Pharmaceuticals SA (Pty) Ltd	Riovex	300	460852	S4	None

Variants

Product	Strength and form	Registration	Status	Schedule	Leaflets
Medpro tenofovir 300 EACH TABLET CONTAINS TENOFOVIR DISOPROXIL FUMARATE 300,0 mg	300	42056042/20.2.8/0560	Cancelled	S4	None
Cipla tenofovir 300 EACH TABLET CONTAINS TENOFOVIR DISOPROXIL FUMARATE 300,0 mg	300	42056142/20.2.8/0561	Cancelled	S4	None
Aspen tenofovir EACH TABLET CONTAINS TENOFOVIR DISOPROXIL FUMARATE 300,0 mg	Not listed	43018143/20.2.8/0181	Registered	S4	None
Sonke tenofovir 300 EACH TABLET CONTAINS TENOFOVIR DISOPROXIL FUMARATE 300,0 mg	300	43069543/20.2.8/0695	Cancelled	S4	None
Zefin 300 MG tablets EACH TABLET CONTAINS TENOFOVIR DISOPROXIL FUMARATE 300,0 mg	300 mgTablets	44030744/20.2.8/0307	Cancelled	S4	None
Cylor 300 MG tablets EACH TABLET CONTAINS TENOFOVIR DISOPROXIL FUMARATE 300,0 mg	300 mgTablets	44030844/20.2.8/0308	Registered	S4	None
Vireno 300 MG tablets EACH TABLET CONTAINS TENOFOVIR DISOPROXIL FUMARATE 300,0 mg	300 mgTablets	44030944/20.2.8/0309	Registered	S4	None
Adco-tenofovir 300 MG EACH TABLET CONTAINS :TENOFOVIR DISOPROXIL FUMARATE EQUIVALENT TO TENOFOVIR DISOPROXIL 300,0 mg	300 mg	44033244/20.2.8/332	Registered	Not determined	None
Taidof 300 MG EACH TABLET CONTAINS TENOFOVIR DISOPROXIL FUMARATE 300,0 mg	300 mg	44033344/20.2.8/0333	Registered	S4	None
Tenofovir propan EACH TABLET CONTAINS TENOFOVIR DISOPROXIL FUMARATE 300,0 mg	Not listed	44033444/20.2.8/0334	Cancelled	S4	None
Ricovir EACH TABLET CONTAINS TENOFOVIR DISOPROXIL FUMARATE 300,0 mg	Not listed	45082545/20.2.8/0825	Registered	S4	None
Hetero tenofovir 300 MG EACH TABLET CONTAINS TENOFOVIR DISOPROXIL FUMARATE 300,0 mg	300 mg	46001946/20.2.8/0019	Registered	S4	None
Tenofovir winthrop EACH TABLET CONTAINS TENOFOVIR DISOPROXIL FUMARATE EQUIVALENT TO TENOFOVIR DISOPROXIL 300,0 mg	Not listed	46004046/20.2.8/0040	Registered	Not determined	None
SPEC tenofovir 300 EACH TABLET CONTAINS TENOFOVIR DISOPROXIL FUMARATE 300,0 mg	300	46051046/20.2.8/0510	Cancelled	S4	None
Riovex 300 Each Tablet contains: Tenofovir Disoproxil Fumarate 300 mg equivalent to Tenofovir Disoproxil 245,0 mg	300	46085246/20.2.8/0852	Registered	S4	None
Tenolaurus Each Tablet contains: Tenofovir Disoproxil Fumarate 300 mg	Not listed	52038852/20.2.8/0388	Cancelled	S4	None
Viread EACH TABLET CONTAINS TENOFOVIR DISOPROXIL FUMARATE 300,0 mg	300mgTablet	A400681A40/20.2.8/0681Approved 24 November 2022	Cancelled	S4	PI PIL

Regulatory status

Where S4 sits on the scale

S0S1S2S3S4S5S6S7S8

Prescription-only medicine.

Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.

Schedule S4, matched to the Consolidated Schedules by ingredient, confidence medium.

Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.

Consolidated Schedules listings for Tenofovir disoproxil fumarate

S4: Tenofovir
Consolidated Schedules 06 July 2026, line 8130

Pharmacological class: Antiviral agents. (class 20.2.8)

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

SAHPRA documents

Schedule verified from official documents

Schedule Verification

Viread, Pharmacare limited û woodmead is scheduled S4 in its official SAHPRA documents, read with 90% confidence.

Professional information (PI)For healthcare professionalsViread, Pharmacare limited û woodmead Patient information leaflet (PIL)For patients and carersViread, Pharmacare limited û woodmead

These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.

Research articles

Loading PubMed articles

Background